Invasix Ltd. together with our subsidiaries, designs, develops and markets minimally invasive aesthetic medical platforms based on our proprietary RFAL™technology to plastic and aesthetic surgeons.
Invasix sells its products through third party distributors in Europe, Asia, South America and Australia.
The BodyTite™ platform by Invasix is under clinical evaluation and it's currently not for sale in the US.
Invasix was founded in 2008 headquarter located in Yokneam Ilit, Israel, with additional offices in the US, Canada, Germany, Hong Kong and Tokyo.
